$12.910
-0.226 (-1.75%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
NPCE 相似图表分析预测
Alphio's NPCE stock price prediction model matches the current Neuropace Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.73 (-1.42%). The 1-week path is $12.29 (-4.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Neuropace Inc 股票吗?
Neuropace Inc is a good buy right now, trading at $12.91, which is significantly below analyst price targets of $18 and $22. The company has shown a gross margin of 82.83% in Q2 2026, indicating strong profitability potential despite current losses. The recent FDA denial poses a risk, as it may impact future revenue growth, but management's confidence in addressing the FDA's concerns suggests a path forward for approval and potential revenue growth.
NPCE 股价于 Friday 收于 $12.91,此前下跌 -1.75%
Neuropace Inc (NPCE) last closed at $12.91, losing -1.75%. These facts feed the 1-day and 1-week NPCE price prediction above.
预测驱动因素
Neuropace Inc(NPCE)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 NPCE 最接近的股票,按相似度排序。
NPCE 季节性分析
Historically the probability of a positive October return for NPCE is 0.00%. December offers the highest probability of a positive month at 100.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
NPCE 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Oct 2026 | $14.20 | $14.75 | $18.13 | +14.27% |
| Nov 2026 | $10.20 | $12.85 | $16.25 | -0.47% |
| Dec 2026 | $16.30 | $17.12 | $19.11 | +32.58% |
2026 年,Neuropace Inc(NPCE)预计区间为 $10.20 至 $19.11。
Neuropace Inc 2026 年月度预测
2026 年 Oct,Neuropace Inc 预计均价 $14.75,最低 $14.20,最高 $18.13。
2026 年 Nov,Neuropace Inc 预计均价 $12.85,最低 $10.20,最高 $16.25。
2026 年 Dec,Neuropace Inc 预计均价 $17.12,最低 $16.30,最高 $19.11。
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。